Shareholder Agreement

SHAREHOLDER AGREEMENT

SCOPE NOTICE. This form assumes that the Company is a Delaware corporation. If it is organized elsewhere, replace the corporate-law provisions, legends/notices, approval mechanics, inspection rights, director-election rules, and cited authorities before use. Complete every schedule; bracketed percentages and periods are drafting prompts, not defaults.

TABLE OF CONTENTS

1. Document Header
2. Definitions

3. Operative Provisions
   3.1 Capitalization and Share Issuance
   3.2 Transfer Restrictions
   3.3 Pre-Emptive Rights
   3.4 Drag-Along / Tag-Along
   3.5 Information & Inspection Rights
   3.6 Board Composition & Voting Agreements

4. Representations & Warranties

5. Covenants & Restrictions
6. Default & Remedies
7. Risk Allocation
8. Dispute Resolution
9. General Provisions
10. Execution Block

1. DOCUMENT HEADER

SHAREHOLDER AGREEMENT (this “Agreement”) is made and entered into as of [EFFECTIVE DATE] (the “Effective Date”) by and among:

(a) [COMPANY NAME], a Delaware corporation (the “Company”); and

(b) the Persons listed on Schedule A hereto (each, a “Shareholder” and, collectively, the “Shareholders”).

The Company and each Shareholder are each a “Party” and collectively the “Parties.”

Recitals

A. The Company has authorized the issuance of shares of its capital stock (the “Shares”).
B. The Shareholders desire to set forth their respective rights and obligations concerning the Company and the Shares.
C. In consideration of the mutual covenants herein, the Parties agree as follows:

2. DEFINITIONS

“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with such Person.

“Agreement” has the meaning set forth in the opening paragraph.

“Arbitration Rules” means the rules selected on Schedule E, if arbitration is selected.

“Board” means the Company’s board of directors.

“Business Day” means any day other than a Saturday, Sunday, or legal holiday in [PRIMARY FORUM].

“Company” has the meaning set forth in the Preamble.

“Charter Documents” means the Company’s certificate of incorporation and bylaws, each as amended.

“Confidential Information” means all non-public information regarding the Company or the Shareholders, whether oral or written, in any form.

“Drag-Along Right” has the meaning given in Section 3.4(a).

“DGCL” means the Delaware General Corporation Law.

“Effective Date” has the meaning set forth in the Preamble.

“Encumbrance” means any lien, pledge, security interest, claim, option, proxy, voting commitment, or other encumbrance or restriction.

“Excluded Issuance” means an issuance identified on Schedule C that is excluded from the contractual participation right in Section 3.3.

“Injunctive Relief” means temporary, preliminary, or permanent injunctive relief or specific performance.

“Law” means any statute, rule, regulation, ordinance, or other binding requirement of any governmental authority.

“Losses” means the losses, liabilities, damages, judgments, and reasonable out-of-pocket costs expressly recoverable under Schedule D.

“Person” means an individual, partnership, corporation, limited liability company, trust, or other entity.

“Permitted Transferee” means a Person identified on Schedule C that satisfies Section 3.2(c).

“Required Approval” means every board, stockholder, class, series, Charter Document, contractual, regulatory, and third-party approval required for the applicable action.

“Representatives” means, with respect to a Person, its directors, officers, employees, attorneys, accountants, advisers, financing sources, and other authorized representatives.

“Securities Act” means the Securities Act of 1933, as amended.

“Shares” has the meaning set forth in the Recitals.

“Tag-Along Right” has the meaning given in Section 3.4(b).

“Transfer” means any direct or indirect sale, assignment, pledge, encumbrance, gift, distribution, or other disposition, whether voluntary, involuntary, by operation of Law, or through a change of control of a Shareholder that is an entity, except as expressly excluded on Schedule C.

“Transfer Notice” means the notice described in Section 3.2(b).

[Add further definitions as necessary.]

3. OPERATIVE PROVISIONS

3.1 Capitalization and Share Issuance

(a) Capitalization. Schedule A shall state the authorized, issued, outstanding, reserved, optioned, and convertible securities of the Company and identify every class or series and its rights.

(b) Issuance Authority. Stock may be issued only after the Board or a properly authorized delegate approves the number, time, and consideration in compliance with 8 Del. C. § 152 and the Charter Documents. The Company also covenants not to issue additional securities without the contractual approval stated on Schedule C. That approval does not replace any Required Approval.

(c) Securities Compliance. Before an issuance or Transfer, the responsible Party shall document an effective registration statement under the Securities Act or the specific exemption relied upon, including any resale conditions. Sophistication, a legend, or this Agreement alone does not establish an exemption under 15 U.S.C. §§ 77d and 77e.

3.2 Transfer Restrictions

(a) General Restriction; Notice. No Shareholder may Transfer Shares except in compliance with this Agreement, the Charter Documents, and applicable Law. The Company shall conspicuously note these restrictions on each certificate and include them in the notice for uncertificated Shares as required by 8 Del. C. § 202; absent the required notation or notice, a restriction may be ineffective against a Person without actual knowledge.

(b) Right of First Refusal (“ROFR”). Before a proposed third-party Transfer, the selling Shareholder shall deliver a Transfer Notice containing the transferee identity, number and class of Shares, price, form of consideration, all material terms, and the binding offer. The Company and then the non-selling Shareholders may exercise the ROFR in the sequence, allocation, and periods stated on Schedule C. Noncash consideration must be valued under the method stated there. If the ROFR is not fully exercised, the proposed Transfer may close only within the stated period and on terms no more favorable to the transferee.

(c) Permitted Transfers. A Transfer to a Permitted Transferee is exempt only from the provisions expressly identified on Schedule C. Before recognition of the Transfer, the transferee must execute a joinder, satisfy applicable securities-law conditions, and deliver evidence reasonably requested concerning authority and beneficial ownership. The transferor remains liable for obligations arising before the Transfer unless expressly released.

(d) Company Administration. The Company may refuse to register a noncompliant Transfer to the extent permitted by Law. Schedule C shall address death, disability, marital or community-property claims, creditor process, bankruptcy, entity-level changes of control, and release or continuation of guarantees; this form supplies no automatic outcome for those events.

3.3 Pre-Emptive Rights

The participation right in this Section is contractual. Delaware stockholders have no statutory preemptive right unless the certificate of incorporation expressly grants one under 8 Del. C. § 102(b)(3). Subject to the Excluded Issuances on Schedule C, the Company shall offer each eligible Shareholder the right to purchase its pro rata share of a proposed issuance on the notice, election, oversubscription, closing, and allocation terms stated on Schedule C. The Board must separately authorize the issuance.

3.4 Drag-Along / Tag-Along

(a) Drag-Along. If the holders and approvals specified on Schedule C approve a bona fide sale transaction, each bound Shareholder shall vote and take the actions expressly required there (the “Drag-Along Right”), subject to all Required Approvals and nonwaivable rights. No dragged Shareholder shall be required, unless separately agreed for additional consideration, to give a business representation, enter a noncompetition or employment covenant, accept joint liability, bear liability exceeding that Shareholder’s proceeds, or receive different per-share consideration from similarly situated holders. Escrow, holdback, purchase-price adjustment, and expense obligations shall be several and allocated as stated on Schedule C.

(b) Tag-Along. If the threshold Transfer stated on Schedule C is proposed, each eligible Shareholder may participate on the same form and amount of per-share consideration (the “Tag-Along Right”), subject to the allocation, notice, election, cutback, and closing provisions stated there. The selling Shareholder shall not complete the Transfer unless the buyer purchases the properly included tag Shares on those terms.

(c) Transaction Form. Schedule C must distinguish a stock sale, merger, asset sale, tender offer, and other change-of-control structure and specify treatment by class or series. Nothing in this Agreement waives a right that applicable Law does not permit the Parties to waive.

3.5 Information & Inspection Rights

(a) Contractual Reports. The Company shall deliver the reports, budgets, capitalization updates, and compliance certificates listed on Schedule C by the dates stated there, subject to privilege, applicable Law, and reasonable confidentiality and use restrictions.

(b) Statutory Inspection. These contractual rights do not waive or replace any right under 8 Del. C. § 220. A statutory demand must satisfy the then-current requirements concerning form, oath, proper purpose, reasonable particularity, and relation to that purpose. The Company may impose confidentiality, use, distribution, and permitted redaction restrictions to the extent § 220 allows.

3.6 Board Composition & Voting Agreements

(a) Board Size. The Parties shall use their voting and other lawful rights to maintain the Board size stated on Schedule C, subject to 8 Del. C. § 141(b) and the Charter Documents.

(b) Nomination Rights. An eligible Shareholder may designate a nominee as stated on Schedule C. The Company shall take lawful action to nominate that Person, and each bound Shareholder shall vote as required by this Agreement. A designation does not itself appoint or remove a director. Removal and vacancy action must comply with § 141, including any classified-board, cumulative-voting, or class-election rule.

(c) Voting Agreement. Under 8 Del. C. § 218(c), each Shareholder agrees in writing to vote its Shares as expressly provided in this Section and Schedule C. Schedule C shall address duration, nominees, replacements, vacancies, proxy mechanics if any, and termination.

(d) Director Authority. No director is required by this Agreement to follow an instruction that the director determines would violate applicable Law. Board-reserved authority remains with the Board except to the extent the DGCL and certificate of incorporation lawfully provide otherwise.

4. REPRESENTATIONS & WARRANTIES

4.1 Company Representations

The Company represents and warrants to each Shareholder that, as of the Effective Date:
(a) Organization; Good Standing. The Company is duly organized, validly existing, and in good standing under Delaware Law;
(b) Authorization. The execution, delivery, and performance of this Agreement have been duly authorized;
(c) No Conflict. The execution and performance do not violate any charter document, Law, or material contract binding upon the Company;
(d) Capitalization and Issuance. Schedule A is complete and accurate as of its stated date, and each issued Share was authorized by the Board or a lawful delegate, issued for the approved consideration, and recorded on the Company’s stock ledger; and
(e) Restrictions and Filings. Schedule C identifies the legends, notices, securities-law basis, contractual consents, and governmental filings applicable to the Shares and the transactions contemplated by this Agreement.

4.2 Shareholder Representations

Each Shareholder, severally and not jointly, represents and warrants to the Company and the other Shareholders that:
(a) Authority. Such Shareholder has full power and authority to execute and deliver this Agreement;
(b) Ownership. Schedule A accurately states the Shares owned of record and beneficially by that Shareholder, subject only to the Encumbrances disclosed there;
(c) No Conflict. Execution and performance do not violate any binding agreement or order applicable to that Shareholder; and
(d) Securities Information. The Shareholder has delivered the investor and beneficial-ownership information reasonably required for the securities-law basis identified on Schedule C. No representation in this Agreement independently establishes an exemption.

4.3 Survival

Schedule D shall state whether each representation survives and, if so, for what period and through what recourse. Do not use indefinite survival without analyzing the governing Law’s accrual, repose, and contractual-limitations rules. Schedule D shall define any fraud carveout and identify nonwaivable claims.

5. COVENANTS & RESTRICTIONS

5.1 Affirmative Covenants of the Company

(a) Legal Compliance. The Company shall comply in all material respects with applicable Laws and maintain the licenses identified on Schedule C;
(b) Maintenance of Books. The Company shall maintain complete and accurate books of account in accordance with [GAAP/IFRS];
(c) Insurance. The Company shall maintain the insurance coverages, limits, deductibles, and tail or run-off terms stated on Schedule C, subject to availability and cost limits stated there.

5.2 Negative Covenants

Without the prior written approval of Shareholders holding at least [THRESHOLD %] of the outstanding Shares, the Company shall not:
(i) Amend its charter documents;
(ii) declare or pay a dividend or distribution except in accordance with the Charter Documents and the rights of each class or series;
(iii) Enter into any transaction with an Affiliate, except on arm’s-length terms;
(iv) Incur indebtedness in excess of [$____] in any fiscal year.

The foregoing is a contractual consent right only. It does not replace Board action, a class or series vote, a Charter Document requirement, or another Required Approval, and it does not authorize a Shareholder to direct an unlawful corporate action.

5.3 Notice & Cure

A Party shall give the notices expressly required by Schedule D after becoming aware of a specified breach. No breach receives an automatic cure period. Each cure period must be tailored to the obligation, outside date, legal or regulatory deadline, and whether cure is possible.

5.4 Confidentiality

Each Shareholder shall use Confidential Information only to monitor its investment, exercise rights, and perform obligations under this Agreement. Disclosure is permitted to Representatives who are bound by confidentiality duties, to financing sources or prospective Permitted Transferees under written restrictions, or when Law requires disclosure after any notice and protective-order steps Law permits. Schedule C shall state exclusions, duration, return or destruction duties, privilege protections, public-company controls, and remedies.

6. DEFAULT & REMEDIES

6.1 Events of Default

The occurrence of any of the following constitutes an “Event of Default”:
(a) a material breach expressly designated as an Event of Default on Schedule D that remains uncured after any applicable stated cure period; or
(b) another event expressly designated on Schedule D, but only to the extent enforcement is not stayed, invalidated, or limited by insolvency or other applicable Law.

6.2 Remedies

Upon an Event of Default, the non-defaulting Party(ies) may:
(a) exercise only the suspension, purchase, sale, dilution, damages, or other remedy expressly stated on Schedule D and permitted by Law;
(b) seek Injunctive Relief or specific performance when the facts and applicable Law support that relief; and
(c) recover attorneys’ fees and costs only if the governing Law and the selected fee provision on Schedule D permit an award.

No remedy automatically suspends voting or statutory inspection rights, effects a forfeiture, or compels a discounted Transfer. Any buyout must use the trigger, valuation date, appraiser process, payment security, offsets, closing conditions, and dispute procedure on Schedule D. Tax counsel shall review any option, agreement, or restriction under 26 U.S.C. § 2703; a contractual price is not necessarily controlling for federal transfer-tax valuation.

7. RISK ALLOCATION

7.1 Selected Indemnities

No broad mutual indemnity applies by default. Schedule D must identify each indemnifying Person, each indemnified Person, the covered representation or covenant, recoverable Losses, exclusions, survival period, and whether the claim is direct or third-party. No Shareholder indemnifies another Party merely because of its status as a Shareholder.

7.2 Procedures

For any selected indemnity, Schedule D shall address notice, prejudice, defense control, conflicts of interest, settlement consent, mitigation, insurance and tax offsets, subrogation, and claim finality.

7.3 Liability Caps

Schedule D shall state the basket, deductible, cap, escrow, setoff, exclusive-remedy rule, and carveouts for each surviving claim category. No claim is uncapped or capped by default.

7.4 Insurance Offset

Any insurance offset applies only as stated on Schedule D, net of reasonable collection costs, premium increases, deductibles, and repayment obligations specified there.

7.5 Force Majeure

Force majeure does not excuse payment, securities-law compliance, confidentiality, voting or transfer steps tied to a transaction deadline, or compliance with Law. Schedule D may excuse a specifically identified nonmonetary covenant only while an event beyond the affected Party’s reasonable control actually prevents performance, subject to prompt notice, mitigation, and any outside date.

8. DISPUTE RESOLUTION

8.1 Governing Law

This Agreement and any dispute arising hereunder shall be governed by and construed in accordance with the Laws of [GOVERNING LAW STATE/COUNTRY], without regard to its conflict-of-laws principles.

8.2 Exclusive Jurisdiction

For a dispute not subject to a selected arbitration provision, each Party submits to the exclusive jurisdiction of the state courts located in [COUNTY, STATE/COUNTRY] and, if federal subject-matter jurisdiction exists, the federal court serving that location. Schedule E must identify a forum able to hear the selected claims and account for any forum provision in the Charter Documents or applicable Law.

8.3 Optional Arbitration

(a) The Parties shall select “court litigation” or “arbitration” on Schedule E. If they select arbitration, the written provision shall identify the covered claims, administrator, Arbitration Rules, seat, number and selection of arbitrators, language, discovery, confidentiality, allocation of fees, interim-relief procedure, and any excluded corporate-law claims.

(b) If the transaction involves commerce and Schedule E selects the Federal Arbitration Act, the Parties intend the written arbitration agreement to be governed by 9 U.S.C. § 2. State arbitration law, international-convention issues, and nonarbitrable claims must be separately analyzed.

(c) Consolidation or joinder is permitted only with all required consents or when the selected Arbitration Rules and applicable Law authorize it.

(d) If arbitration is selected, the Parties agree that judgment may be entered on the award and designate the court for confirmation on Schedule E. Any application under 9 U.S.C. § 9 must comply with its applicable timing, forum, notice, and other requirements.

8.4 Injunctive Relief Carve-Out

Nothing in a selected arbitration clause prevents a Party from requesting temporary or emergency relief from an arbitrator or a court when the selected rules and applicable Law permit it. A request for waiver or reduction of security does not bind the court.

8.5 Jury Trial Waiver

FOR CLAIMS LITIGATED IN COURT, EACH PARTY KNOWINGLY AND VOLUNTARILY WAIVES A JURY TRIAL TO THE FULLEST EXTENT THE GOVERNING LAW PERMITS. SCHEDULE E SHALL INCLUDE ANY FORMAT OR CONSPICUOUSNESS REQUIREMENT OF THAT LAW.

9. GENERAL PROVISIONS

9.1 Amendments and Waivers

No amendment or waiver is effective unless written and approved under Schedule E. No amendment may disproportionately and adversely affect a Shareholder, alter a class or series right, impose new personal liability, or reduce accrued payment rights without every separate consent required by Schedule E, the Charter Documents, and applicable Law. An Agreement amendment does not itself amend the Charter Documents.

9.2 Assignment

No Party may assign or delegate this Agreement except as stated on Schedule C. A permitted assignment does not release the assignor unless the required Parties expressly agree in writing, and a Transfer of Shares is not recognized until Section 3.2 is satisfied.

9.3 Successors and Assigns

This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns.

9.4 Severability

If a provision is invalid or unenforceable, the remaining provisions remain effective to the extent the governing Law permits. A court or arbitrator may reform a provision only if authorized by that Law and only without rewriting the Parties’ material bargain.

9.5 Entire Agreement

This Agreement (including all schedules and exhibits) constitutes the entire agreement among the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings, and negotiations.

9.6 Counterparts; Electronic Signatures

This Agreement may be executed in counterparts, each deemed an original and together one instrument. The Parties consent to electronic signatures and delivery, subject to any separate execution, consent, stock-certificate, notarization, or filing form required by applicable Law.

9.7 Notices

All notices shall be in writing and deemed given: (i) when delivered personally; (ii) on the next Business Day after being sent by a recognized overnight courier; or (iii) on the third Business Day after being mailed by certified mail, return receipt requested, to the addresses set forth on Schedule B, or to such other address as a Party may designate by notice.

9.8 No Third-Party Beneficiaries

Except for a Person expressly identified as a beneficiary of a selected indemnity on Schedule D, this Agreement confers no rights on any non-Party.

9.9 Relationship to Corporate Documents

The Parties shall not require the Company or a director to take an action that violates applicable Law or the Charter Documents. If an intended governance or stock right must appear in the certificate of incorporation, bylaws, stock terms, board resolutions, certificate legend, or uncertificated-share notice to be effective, the Parties shall complete that separate action and filing; this Agreement alone is not a substitute.

10. EXECUTION BLOCK

IN WITNESS WHEREOF, the Parties have executed this Shareholder Agreement as of the Effective Date.

[Repeat Shareholder signature blocks as necessary.]

Schedule A – Shareholder Ownership

Schedule B – Notice Addresses

Schedule C – Governance, Issuance, Transfer, ROFR, Participation, Drag, Tag, and Information Terms

[Complete all thresholds, classes, election periods, allocation rules, legends/notices, securities-law basis, and Required Approvals.]

Schedule D – Defaults, Valuation, Buyout, Survival, Indemnity, Caps, and Remedies

[Complete each trigger, cure period, valuation method, appraiser process, payment terms, covered claim, recourse source, cap, carveout, and fee rule.]

Schedule E – Governing Law, Court or Arbitration Selection, Amendment Thresholds, and Mandatory Forums

[Select exactly one merits forum and complete every implementation term.]

SOURCES AND REFERENCES

• Delaware Code — 8 Del. C. § 102
• Delaware Code — 8 Del. C. § 141
• Delaware Code — 8 Del. C. § 152
• Delaware Code — 8 Del. C. § 202
• Delaware Code — 8 Del. C. § 218
• Delaware Code — 8 Del. C. § 220
• Office of the Law Revision Counsel — 15 U.S.C. § 77d
• Office of the Law Revision Counsel — 15 U.S.C. § 77e
• Office of the Law Revision Counsel — 9 U.S.C. § 2
• Office of the Law Revision Counsel — 9 U.S.C. § 9
• Office of the Law Revision Counsel — 26 U.S.C. § 2703